XZXia Zhang

Xia Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xia Zhang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Li

    Guizhou Forestry School, Guiyang, 550001, China

    3 shared publications
  • Rui Meng

    School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China

    3 shared publications
  • Hua‐Yuan Yang

    School of Pharmaceutical Sciences Guizhou University Guiyang China

    2 shared publications
  • Xing Yang

    School of Pharmaceutical Sciences, Guizhou University, Guiyang, 550025, China

    2 shared publications
  • Zhi‐Wen Wan

    School of Pharmaceutical Sciences Guizhou University Guiyang China

    2 shared publications
  • Aftab Yaseen

    State Key Laboratory of Phytochemistry and Plant Resources in West China, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany Chinese Academy of Sciences Kunming China

    1 shared publication

Latest Publications

  • Antioxidant and Hypoglycemic Activity of Polysaccharides With Different Tissues From Rosa roxburghii f. eseiosa Ku

    by Zhi‐Wen Wan, Rui Meng, Hua‐Yuan Yang, Xing Yang, Qin Zhou, Min Wu, Bin Li, Xia Zhang

    Rosa roxburghii f. eseiosa Ku, a thornless variety of Rosa roxburghii Tratt, remains underexplored regarding the tissue‐specific functionality and structure‐activity relationships of its polysaccharides. This study systematically investigated the composition and bioactivities of polysaccharides extracted from the fruit, root, stem, and thick stem of this variant. Using gradient ethanol precipitation (40%, 60%, and 80%), polysaccharides with distinct molecular weight (M w ) profiles were obtained. All isolates were identified as acidic heteropolysaccharides with complex and tissue‐dependent monosaccharide compositions. Fractions precipitated with 60% and 80% ethanol exhibited lower M w s and significantly enhanced bioactivities, including potent radical scavenging capacity and α ‐glucosidase inhibition. Notably, RREK‐R60, the crude polysaccharide obtained from the roots of Rosa roxburghii f. eseiosa Ku via 60% ethanol precipitation, exhibited a notable α ‐glucosidase inhibition rate of 92.91%. Structural analysis revealed tissue‐specific traits, such as the unique presence of N‐acetylglucosamine in fruit and root samples, along with elevated uronic acid, galactose, and arabinose content, which correlated strongly with bioactivity. These findings underscore the potential of Rosa roxburghii f. eseiosa Ku polysaccharides as functional food ingredients or anti‐diabetic agents. Further in vivo studies and detailed structural elucidation are warranted to fully establish their structure‐activity relationships.


  • Ultrasonic‐Assisted Extraction, Structural Characteristics, and Activity of Polysaccharides From Gymnocladus chinensis Baill

    by Rui Meng, Zhi‐Wen Wan, Hua‐Yuan Yang, Lv Wu, Aftab Yaseen, Bin Li, Xia Zhang

    In this study, the response surface method (RSM) was used to determine the optimal parameters of ultrasonic‐assisted extraction of Gymnocladus chinensis Baill. polysaccharides (GCBPs). The optimal extraction conditions were as follows: a liquid–solid ratio of 50.4 mL/g, an extraction temperature of 60°C, an extraction time of 43 min, and an extraction power of 240 W. Under these conditions, the extraction rate of GCBP reached 50.1%. Three fractions of GCBP‐40, GCBP‐60, and GCBP‐80 with sugar contents of 64.33%, 59.16%, and 59.46% were obtained by different concentrations of ethanol purification. All the three fractions consisted of six monosaccharides with different ratios, namely, Man, Rha, Gal, Glu, Ara, and Xyl. From Congo red test, it is confirmed that all three fractions could have a triple helix structure. In addition, the antioxidant and hypoglycemic experiments showed that all three components had excellent antioxidant activity (2,2‐diphenyl‐1‐picrylhydrazyl [DPPH] free‐radical scavenging activity, 2,2‐azino‐bis (3‐ethylbenzothiazoline‐6‐sulfonic acid) [ABTS] free‐radical scavenging activity, and OH − free‐radical scavenging activity) and hypoglycemic activity (α‐glucosidase inhibitory activity).


  • Open Access

    Network Pharmacology Analysis, Molecular Docking Integrated Experimental Verification Reveal the Mechanism of Gynostemma pentaphyllum in the Treatment of Type II Diabetes by Regulating the IRS1/PI3K/Akt Signaling Pathway

    by Songqin Yang, Mao Zhao, Mingxing Lu, Yuhan Feng, Xia Zhang, Daoping Wang, Wenwen Jiang

    Gynostemma pentaphyllum (Thunb.) Makino (GP), a plant with homology of medicine and food, as a traditional Chinese medicine, possesses promising biological activities in the prevention and treatment of type 2 diabetes mellitus (T2DM). However, the material basis and the mechanism of action of GP in the treatment of T2DM have not been fully elucidated. This study aimed to clarify the active components, potential targets and signaling pathways of GP in treating T2DM. The chemical ingredients of GP were collected by combining UPLC-HRMS analysis and literature research. Network pharmacology revealed that GP had 32 components and 326 potential targets in treating T2DM. The results showed that GP affected T2DM by mediating the insulin resistance signaling pathway, PI3K/Akt signaling pathway and FoxO1 signaling pathway, which had a close relationship with T2DM. Molecular docking results showed that STAT3, PIK3CA, AKT1, EGFR, VEGFA and INSR had high affinity with the active compounds of GP. In vitro, GP extracts obviously increased the glucose uptake and glucose consumption in IR-HepG2 cells. GP extracts increased the levels of PI3K, p-AKT, p-GSK3β and p-FoxO1 and decreased the expression of p-IRS1, p-GS, PEPCK and G6Pase, which indicated that GP could promote glycogen synthesis and inhibit gluconeogenesis by regulating the IRS1/PI3K/Akt signaling pathway. The results demonstrated that GP could improve insulin resistance by promoting glucose uptake and glycogen synthesis and inhibiting gluconeogenesis through regulating the IRS1/PI3K/Akt signaling pathway, which might be a potential alternative therapy for T2DM.